Richard G. Bostedor

Alendronate Is a Specific, Nanomolar Inhibitor of Farnesyl Diphosphate Synthase

James D. Bergstrom, Richard G. Bostedor, P. Masarachia et al. · Archives of Biochemistry and Biophysics · 2000 · 398 citations

Biochemistry, Natural Sciences, Biocatalysis +6

Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivo

John I. Germershausen, V. M. Hunt, Richard G. Bostedor et al. · Biochemical and Biophysical Research Communications · 1989 · 172 citations

Inflammation, Cholesterol-lowering Agents Lovastatin, Cardiovascular Disease +10

Farnesol-derived Dicarboxylic Acids in the Urine of Animals Treated with Zaragozic Acid A or with Farnesol

Richard G. Bostedor, John D. Karkas, Byron H. Arison et al. · Journal of Biological Chemistry · 1997 · 67 citations · Full text

Animal Physiology, Animals Treated, Pharmacological Study +12

Cloning, analysis, and bacterial expression of human farnesyl pyrophosphate synthetase and its regulation in Hep G2 cells

B T Sheares, Sylvia S. White, David T. Molowa et al. · Biochemistry · 1989 · 59 citations

Molecular Regulation, Molecular Biology, Molecular Genetics +22

Massive Production of Farnesol-Derived Dicarboxylic Acids in Mice Treated with the Squalene Synthase Inhibitor Zaragozic Acid A

Sanskruti Vaidya, Richard G. Bostedor, Marc M. Kurtz et al. · Archives of Biochemistry and Biophysics · 1998 · 53 citations

Biochemistry, Medicine, Mice Treated +6